Abe M,Masakane I,Wada A,Nakai S,Nitta K,Nakamoto H K .2021 .Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study. Clin. Kidney, 15(3) : 473-483.
And Alternative Medicine EC .2023 .Retracted: Effects of high flux hemodialysis combined with L-carnitine on microinflammation and arteriovenous fistula in maintenance hemodialysis patients. Evidence-based complementary and alternative medicine: eCAM, : 9846504.
Battaglia Y,Shroff R,Meijers B,Nistor I,Alfano G,Franssen C,Luyckx V,Liakopoulos V,Mantovani A,Baciga F,Caccia F,Momentè C,Davenport A,Blankestijn PJ,Covic A,Combe C,Basile C C .2025 .Nephrology, dialysis, transplantation: official publication of the European Dialysis. Advance online publication., : .
Bignardi PR,Delfino VDA .2024 .Is hemodiafiltration superior to high-flow hemodialysis in reducing all-cause and cardiovascular mortality in kidney failure patients? A meta-analysis of randomized controlled trials. Hemodialysis international. Hemodial Int, 28(2) : 139-147.
Caskey FJ,Procter S,MacNeill SJ,Wade J,Taylor J,Rooshenas L,Liu Y,Annaw A,Alloway K,Davenport A,Power A,Farrington K,Mitra S,Wheeler DC,Law K,Lewis-White H,Ben-Shlomo Y,Hollingworth W,Donovan J,Lane JA .2022 .). The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes. Trials, 23(1) : 532.
Chen CY,Liou HH,Chang MY,Wang HH,Lee YC,Ho LC,Lin TM,Hung SY .2022 .The use of a low-flux hemo-dialyzer is associated with impaired platelet aggregation in patients undergoing chronic hemodialysis. Medicine, 101(43) : e31623.
Chi XG,Ma Z,Zhang WB,Cai Q,Chen YZ,Ding DL .2021 .Effects of high-flux hemodialysis combined with levocarnitine on vascular calcification, microinflammation, hepcidin, and malnutrition of elderly patients on maintenance hemodialysis. Ann. Palliat. Med, 10(3) : 3286-3298.
De Schuyter K,Colin PJ,Vanommeslaeghe F,Delanghe S,De Cock P,Veys N,De Paepe P,Van Biesen W,Eloot S W .2021 .Optimizing amoxicillin/clavulanic acid dosing regimens in patients on maintenance high-flux hemodialysis. Am J Kidney Dis., 78(1) : 153-156.
Huang W,Bai J,Zhang Y,Qiu D,Wei L,Zhao C,Ren Z,Wang Q,Ren K,Cao N K .2024 .Effects of low-flux and high-flux hemodialysis on the survival of elderly maintenance hemodialysis patients. Ren, 46(1) : 2338217.
Kim HJ,Seong EY,Lee W,Kim S,Ahn HS,Yeom J,Kim K,Kwon CH,Song SH .2021 .Comparative analysis of therapeutic effects between medium cut-off and high flux dialyzers using metabolomics and proteomics: exploratory, prospective study in hemodialysis. Sci. Rep, 11(1) : 17335.
Lim JH,Park Y,Yook JM,Choi SY,Jung HY,Choi JY,Park SH,Kim CD,Kim YL,Cho JH .2020 .Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients. Sci. Rep, 10(1) : 7780.
Morgans HA,Chadha V,Warady BA .2021 .The role of carnitine in maintenance dialysis therapy. Pediatric nephrology, 36(8) : 2545-2551.
Rehman S,Farhan M,Kumar S,Sarfraz MR,Naveed A,Khan MT,Huq H MT .2025 .Efficacy of intravenous versus oral administration of levocarnitine in maintenance hemodialysis patients: A randomized controlled trial investigating therapeutic approaches to renal anemia. Health Sci. Rep, 8(1) : e70297.
Rehman S,Farhan M,Naveed A,Mahmood S,Khattak MI .2024 .Impact of haemodialysis on plasma carnitine concentrations in haemodialysis patients. JPMA., 74(2) : 294-298.
Rodriguez A,Morena M,Bargnoux AS,Chenine L,LerayMoragues H,Cristol JP,Canaud B .2021 .Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration. Artificial organs, 45(8) : E280-E292.
Takashima H,Maruyama T,Abe M .2021 .Significance of levocarnitine treatment in dialysis patients. Nutrients, 13(4) : 1219.
Wang Y,Gan LY,Yang B,Guan HJ,Zuo L HJ .2023 .High-flux hemodialysis does not increase vitamin B loss compared with Low-flux hemodialysis. JREN., 33(5) : 676-681.
Wardoyo EY,Sari AP,Djojo AY,Sarwono J,Mokoagow MI,Darnindro N,Nasarudin J,Epriliawati M,Manurung A,Iskandar M,Wibisana KA,Widyastuti AAA,Mardiyah R .2022 .Hemoperfusion as an adjuvant therapy in maintenance hemodialysis patients with severe COVID-19: A single centre experience. Acta Med, 54(3) : 444-450.
Yang J,Ke G,Liao Y,Guo Y,Gao X Y .2022 .Efficacy of medium cut-off dialyzers and comparison with highflux dialyzers in patients on maintenance hemodialysis: A systematic review and meta-analysis. Ther Apher Dial., 26(4) : 756-768.
Zakrzewska A,Biedunkiewicz J,Komorniczak M,Jankowska M,Jasiulewicz K,Płonka N,Biedunkiewicz B,Małgorzewicz S,Tarasewicz A,Puchalska-Reglińska E,Siebert J,Dębska-Ślizień A,Tylicki L A .2024 .Intradialytic tolerance and recovery time in different high-efficiency hemodialysis modalities. J. Clin. Med, 13(2) : 326.
Zelenitsky SA,Ariano RE .2022 .An updated vancomycin dosing protocol for initiating therapy in patients undergoing intermittent high-flux hemodialysis. Am J Health Syst Pharm., 79(12) : 1006-1010.
Zhao X,Gan L,Hou FF,Liang X,Chen X,Chen Y,Zuo L Z .2024 .The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients. Ren, 46(1) : 2290922.
Zheng Y,Tang Z,You L,Wu Y,Liu J,Xue J .2020 .Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis. Ren, 42(1) : 580-586.
Yang Zhou J,T Zhou J .2020 .The efficacy of L-carnitine in improving malnutrition in patients on maintenance hemodialysis: A meta-analysis. Biosci. Rep, 40(6) : BSR20201639.